SEC Form 3 · accession 0001171843-17-007188
Zomedica Corp. · ZOMDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert DiMarzo
Officer — EVP of Global Strategy
Period of report
Nov 20, 2017
Accepted (ET)
Nov 21, 2017 · 6:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001684144
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | holding | — | — | — | 134,880 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.20 | holding | — | — | — | Dec 21, 2016 | Dec 21, 2018 | Common Shares, without par value | 100,000 | — | D |
| Stock Option (right to buy)F1 | $1.20 | holding | — | — | — | Feb 24, 2017 | Feb 24, 2019 | Common Shares, without par value | 500,000 | — | D |
| Stock Option (right to buy)F1 | $2.20 | holding | — | — | — | Aug 14, 2017 | Aug 14, 2019 | Common Shares, without par value | 250,000 | — | D |
Explanation of responses
- F1The options vested upon grant. The option is currently fully vested.
Remarks
Exhibit List Exhibit 24 - Power of Attorney